CTSO Cytosorbents Corp

CytoSorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses and cardiac surgery.

As of 10/18/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  08/08/2006
Outstanding shares:  43,369,000
Average volume:  281,825
Market cap:   $259,780,310
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    23283X206
ISIN:        US23283X2062
Valuation   (See tab for details)
PE ratio:   -24.52
PB ratio:   3.41
PS ratio:   5.76
Return on equity:   -13.93%
Net income %:   -22.96%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy